GSTF9 Antibody

What are the primary research applications for GDF9 antibodies in ovarian biology studies?

GDF9 antibodies are primarily used to investigate:

• Follicle development: Tracking GDF9 expression during primordial-to-primary follicle transitions using immunohistochemistry (IHC) or immunofluorescence (IF) .

• Granulosa cell function: Measuring GDF9-mediated regulation of STAR expression and progesterone production via western blot (WB) or ELISA .

• Cell cycle modulation: Analyzing CCND1/CCNE1 upregulation in granulosa cells using flow cytometry or immunocytochemistry (ICC) .

Key validation controls:

• Knockout cell lines (CRISPR/Cas9-edited) to confirm specificity .

• Peptide blocking assays to verify epitope recognition .

How to validate species cross-reactivity of GDF9 antibodies in rodent models?

Methodology:

• Sequence alignment: Compare human GDF9 epitopes (UniProt: O60383) with rodent homologs to predict reactivity .

• Empirical testing:

  • Perform WB on lysates from human, mouse, and rat ovarian tissues.

  • Use secondary antibodies with species-specific conjugates to minimize cross-reactivity artifacts .

Example cross-reactivity validation (WB results):

Data adapted from Aviva Systems Biology (OAAN00949) .

What controls are essential for GDF9 detection in western blot assays?

• Negative controls:

  • Lysates from GDF9-knockout cell lines (CRISPR/ZFN-edited) .

  • Secondary antibody-only lanes .

• Positive controls:

  • Recombinant GST-tagged GDF9 protein (35–38 kDa range) .

• Loading controls: β-actin or GAPDH to normalize protein levels .

Critical step: Optimize antibody concentration (e.g., 1:500–1:2,000 dilution) using titration curves to maximize signal-to-noise ratios .

How to resolve conflicting IHC results when using GDF9 antibodies across tissue fixation methods?

Experimental troubleshooting:

• Fixation variability: Compare paraformaldehyde (PFA) vs. alcohol-based fixation. PFA preserves epitopes better for GDF9 detection .

• Antigen retrieval: Test citrate buffer (pH 6.0) vs. EDTA (pH 8.0) to optimize epitope exposure .

• Quantitative validation: Use RNAscope® or qPCR to correlate protein and mRNA expression levels in disputed samples .

What orthogonal validation methods confirm GDF9 antibody specificity in CRISPR-edited cell lines?

Multipronged validation pipeline:

• Genetic knockout: Compare staining in wild-type vs. GDF9-KO granulosa cells .

• Functional assays: Measure progesterone secretion (ELISA) in antibody-treated vs. untreated cells .

• Mass spectrometry: Immunoprecipitate GDF9 and confirm identity via LC-MS/MS .

Example CRISPR validation data:

How to optimize GDF9 antibody concentrations for multiplex flow cytometry panels?

Titration protocol:

• Staining matrix: Test antibody dilutions (e.g., 0.25–2 µg/mL) with viability dyes (e.g., Zombie NIR) to exclude dead cells .

• Signal-to-noise (SI) calculation:

  • SI = (Median fluorescence intensity (MFI) of stained sample) / (MFI of isotype control)

  • Aim for SI ≥ 5 .

Example titration results:

Optimal concentration: 0.5 µg/mL balances SI and reagent cost .